New England Biolabs launches primer tool for SARS-CoV-2 variant tracking
New England Biolabs has launched an open access, web-based tool for monitoring the emergence of SARS-CoV-2 variants and their potential effect on COVID-19 diagnostic tests. Read More
Nucleome resolves 3D genome structure at single-base-pair level
Nucleome Therapeutics has gained an exclusive license from its academic founders at the University of Oxford to a micro capture-C method that maps the 3D genome structure with single-base-pair resolution. Read More
Valo Health, Khosla Ventures Acquisition to merge
Valo Health and Khosla Ventures Acquisition plan to merge to form a publicly traded company with an estimated pro forma market value of approximately $2.8 billion. Read More
Genetic Technologies gets patent for identifying genome variations
Genetic Technologies was recently granted a patent for methods to identify variations that occur in the human genome and relate those variations to the genetic basis of disease and drug response. Read More
Strateos nabs $56M for SmartLab Platform
Strateos announced it closed on $56 million in financing to continue to drive innovations on its SmartLab Platform. Read More
U.S. to donate 500M doses of Pfizer-BioNTech COVID-19 vaccines
The U.S. government is buying 500 million doses of the Pfizer-BioNTech COVID-19 vaccine to distribute to low- and lower middle-income countries and organizations that support them, according to a release from the companies. Read More
Codexis, Takeda expand gene therapy collaboration
Codexis has expanded its strategic collaboration and license agreement with Takeda Pharmaceutical for the research and development of an additional gene therapy for a lysosomal storage disorder, bringing the total number of programs under the agreement to four. Read More
Veranome, Portal to develop omics workflow in clinical samples
Veranome Biosystems and Portal Bioscience have entered into a codevelopment agreement to develop products that overcome analytical challenges posed by varying RNA degradation levels found in clinical specimens. Read More
10x Genomics launches FFPE Visium assay for research use
10x Genomics has launched its new Visium Spatial Gene Expression assay for formalin-fixed, paraffin-embedded (FFPE) samples, which gives researchers the ability to assess the whole transcriptome across an entire FFPE tissue sample. Read More
QPharma launches Neolytica for AI-focused analytics
QPharma has launched Neolytica, a new subsidiary focused on artificial intelligence (AI) for healthcare analytics. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
